Arena Pharmaceuticals (ARNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 12-2010 | 12-2009 | 12-2008 | 12-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 57,632 | 150,669 | 94,733 | 73,329 | 386,989 |
| Marketable Securities | N/A | N/A | 20,716 | 36,800 | 11,196 |
| Receivables | 607 | 3,499 | 1,415 | 1,823 | 1,901 |
| TOTAL | $60,260 | $156,806 | $121,273 | $116,983 | $409,248 |
| Non-Current Assets | |||||
| PPE Net | 82,066 | 91,533 | 95,445 | 102,740 | 65,940 |
| Intangibles | 11,032 | 12,031 | 13,123 | 16,262 | 4,875 |
| Other Non-Current Assets | 3,771 | 5,992 | 6,437 | 5,346 | 7,443 |
| TOTAL | $96,869 | $109,556 | $115,005 | $124,348 | $78,258 |
| Total Assets | $157,129 | $266,362 | $236,278 | $241,331 | $487,506 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,294 | 5,017 | 9,677 | 16,989 | 10,292 |
| Accrued Expenses | 4,280 | 5,663 | 6,207 | 29,800 | 19,766 |
| Other current liabilities | 0 | 607 | 0 | N/A | N/A |
| TOTAL | $14,360 | $36,866 | $20,687 | $47,199 | $30,289 |
| Non-Current Liabilities | |||||
| Long Term Debt | 14,698 | 27,403 | 57,049 | 8,567 | N/A |
| Deferred Revenues | 3,473 | 3,846 | 4,086 | N/A | N/A |
| Other Non-Current Liabilities | 1,617 | 1,664 | 6,642 | 0 | 0 |
| TOTAL | $132,207 | $149,481 | $141,024 | $76,500 | $66,918 |
| Total Liabilities | $146,567 | $186,347 | $161,711 | $123,699 | $97,207 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 18,042 | 12,152 | 10,113 | 7,419 | 7,376 |
| Common Shares | 15 | 12 | 10 | 8 | 8 |
| Retained earnings | -1,079,751 | -970,527 | -864,587 | -718,936 | -479,451 |
| Other shareholders' equity | 4,673 | 4,896 | 875 | 186 | 53,829 |
| TOTAL | $10,562 | $80,015 | $74,567 | $117,632 | $390,299 |
| Total Liabilities And Equity | $157,129 | $266,362 | $236,278 | $241,331 | $487,506 |